News

Misoprostol Dosage Chart - new release!

The new FIGO 2017 misoprostol-only dosage chart has been released! An update from the widely used 2012 chart detailing recommended dosages of misoprostol when used by itself for a variety of gynecological and obstetrical indications has been revised and expanded by an expert group and is now...

IJGO impact factor soars to 2.174!

FIGO's journal, the International Journal of Gynecology and Obstetrics (IJGO), has seen its impact factor soar to 2.174, its highest ever! The journal’s ranking has also increased to 36/79 journals (up from 47/80). Visit the journal online. Follow IJGO on Twitter. Visit the IJGO Facebook...

FIGO condolences: Dr Babatunde Osotimehin

Professor CN Purandare, FIGO President, said: 'FIGO wishes to pass on its sincere condolences to UNFPA on the very sad passing of Dr Babatunde Osotimehin , its Executive Director. 'Dr Osotimehin was truly a great global health champion, and highly regarded for his work on sexual and...

Hot flushes linked to depression

A new study has linked hot flushes to a greater risk of depression in women. The study, conducted by a group of researchers from Monash University, Australia, looked at the impact of hot flushes and a number of other independent factors on the risk of depression in women 65 or older. They found...

HPV testing ‘can lead to earlier detection of cervical pre-cancer’

Women who receive human papillomavirus (HPV) testing, as well as a cervical smear, receive a faster, more complete diagnosis of possible cervical pre-cancer. This is according to a study conducted by Queen Mary University of London (QMUL), UK, and the University of New Mexico (UNM) Comprehensive...

Breast implants ‘could affect ECG results’

New research has revealed that breast implants may impede an electrocardiogram (ECG), which could result in a false heart attack diagnosis. The study was conducted by Dr Sok-Sithikun Bun, a cardiologist at Princess Grace Hospital, Monaco, and colleagues. An ECG records the heart’s electrical...

HIV-positive women ‘more likely to transmit cytomegalovirus to babies’

HIV-positive women with cytomegalovirus (CMV) in their urine at the time of labour and delivery are more than five times likelier to transmit HIV to their babies than HIV-positive women without CMV, according to a new study led by the University of California, Los Angeles (UCLA). The researchers...

Late premature birth ‘increases hospitalisation risk for respiratory illness’

A new study of children up to two years of age has revealed that those born late preterm (34-36 weeks) had a significantly greater risk of recurrent hospitalisation for respiratory illness compared to those who were born full term (later than 37 weeks). It was also found that the repeat hospital...

Stillbirth rate in UK falls between 2013 and 2015

The stillbirth rate in the UK fell by almost eight per cent between 2013 and 2015, according to new research. The MBRRACE-UK report found that in 2015 the stillbirth rate was 3.87 per 1,000 total births. This had fallen from 4.20 per 1,000 total births in 2013. However, the report also found that...

Most mothers ‘criticised over parenting skills’

Some six out of ten mothers of children aged up to five-years-old report feeling criticised about parenting, according to a new report from the CS Mott Children's Hospital National Poll on Children's Health at the University of Michigan, US. The report is based on responses from a national...

Researcher to ‘train virus to kill ovarian cancer’

A UK-based scientist is beginning work to establish whether a virus can be ‘trained’ to fight ovarian cancer. Senior lecturer at Cardiff University, UK, Dr Alan Parker will examine whether the Ad5 virus, which can cause airway infections, can be genetically modified to destroy cancer...

Foetal immunity ‘develops in second trimester’

Scientists in Singapore have discovered that a foetus' immune system is established as early as the second trimester of pregnancy, and may be able to initiate immune responses independently of the mother's immune system. The researchers are from the Agency for Science, Technology and...

Kadcyla to be made available through NHS England

The drug trastuzumab emtansine - known as Kadcyla - is going to be made routinely available for patients in England, UK, with an advanced type of breast cancer. NHS England has announced that a discounted deal has been agreed with the drug manufacturer. This has been backed by the National...